Wednesday, 30 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results · Q3 FY26

Nectar Lifesciences Q3 FY26 Results: Net Profit ₹14.3 Cr, Up 83.3% YoY

Nectar Lifesciences Ltd reported net profit of ₹14.3 Cr (+83.3% YoY) for Q3 FY26.

Q3 FY26 at a glance · ₹ crore
MetricQ3 FY26Q2 FY26Q3 FY25
Other income0.70.00.5
Total income0.70.70.5
Exceptional items-88.20.00.0
Net profit14.3-176.07.8
Operating marginn/m71.4%80.0%

A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.

Growth
Net profit, year on year+83.30%
Source

BSE results filing, NSE: NECLIFE. Figures extracted from the filing.

Read the filing ↗

Nectar Lifesciences Ltd: key numbers

Share price
₹10.55
Market cap
₹236.6 Cr
Revenue (annual)
₹0.00 Cr
Net profit (annual)
₹-292.9 Cr
P/E (TTM)
-1.0×Sector 49.8×
Promoter holding
51.84%+0.00% QoQ
FII holding
0.50%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Nectar Lifesciences Ltd

All →
16:11 IST BSE
Management Change

Nectar Lifesciences Management Change

Nectar Lifesciences Limited has announced the appointment of Dr. Gunmala Suri as a Director. Additionally, three other directors have been re-appointed to the Board.

12:25 IST NSE
Annual General Meeting

Nectar Lifesciences Annual General Meeting

Nectar Lifesciences filed proceedings of its 31st AGM held September 18, 2026. Resolutions covered adoption of FY26 financials and director re-appointments.

11:41 IST BSE
Annual Report

Nectar Lifesciences Annual Report

Nectar Lifesciences Ltd. has released its Annual Report for FY 2025-26. The 31st Annual General Meeting is scheduled for September 18, 2026, via video conferencing.

11:39 IST BSE
Other Announcement

Nectar Lifesciences Other Announcement

Nectar Lifesciences Limited announced a change in its corporate office address, moving to Godrej Eternia in Chandigarh effective September 15, 2026.

21:19 IST BSE
Management Change

Nectar Lifesciences Management Change

Nectar Lifesciences Limited has appointed Dr. Gunmala Suri as an Additional Director, effective August 15, 2026.

21:13 IST BSE
Annual General Meeting

Nectar Lifesciences Annual General Meeting

Nectar Lifesciences Ltd. has announced that its 31st Annual General Meeting will be held on September 18, 2026. The book closure period is set from September 12, 2026, to September 18, 2026.